SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
09-Jun-23 7:03 PM View: | Krystal Biotech, Inc. (KRYS) | 09-Jun-23 | Sale | 18,935 | $128.77 | $2,438,220.00 | (15%) 126.3K to 107.36K | |
09-Jun-23 7:03 PM View: | Krystal Biotech, Inc. (KRYS) | 08-Jun-23 | Private Sale | 31,065 | $128.11 | $3,979,850.00 | (20%) 157.36K to 126.3K | |
23-May-23 4:20 PM View: | Krystal Biotech, Inc. (KRYS) | 19-May-23 | Private Sale (Planned) | 50,000 | $95.02 | $4,751,180.00 | (24%) 207.36K to 157.36K | |
11-May-23 4:30 PM View: | Krystal Biotech, Inc. (KRYS) | 09-May-23 | Private Sale (Planned) | 17,100 | $90.74 | $1,551,580.00 | (8%) 224.46K to 207.36K | |
21-Apr-23 4:10 PM View: | Krystal Biotech, Inc. (KRYS) | 19-Apr-23 | Private Sale (Planned) | 7,900 | $90.32 | $713,493.00 | (3%) 232.36K to 224.46K | |
23-Sep-22 4:25 PM View: | Allakos Inc. (ALLK) | 21-Sep-22 | Private Purchase | 475,000 | $5.02 | $2,384,500.00 | 6% 8.58M to 9.05M | |
02-Feb-22 10:00 PM View: | Krystal Biotech, Inc. (KRYS) | 30-Dec-21 | Gift | 34,000 | -- | -- | (13%) 266.36K to 232.36K | |
14-Dec-21 4:11 PM View: | Krystal Biotech, Inc. (KRYS) | 10-Dec-21 | Market Sale Duplicate | 100,000 | $70.50 | $7,050,000.00 | (27%) 366.36K to 266.36K | (1%) |
28-May-21 4:16 PM View: | Esperion Therapeutics, Inc. (ESPR) | 27-May-21 | Grant | 12,376 | -- | -- | 35% 35.64K to 48.01K | |
30-Mar-21 6:27 PM View: | Allakos Inc. (ALLK) | 26-Mar-21 | Market Sale | 17,308 | $115.17 | $1,993,290.00 | (< 1%) 8.59M to 8.58M | 14% |
24-Mar-21 7:21 PM View: | Allakos Inc. (ALLK) | 22-Mar-21 | Market Sale | 13,148 | $119.70 | $1,573,790.00 | (< 1%) 8.61M to 8.59M | 17% |
16-Mar-21 4:17 PM View: | Allakos Inc. (ALLK) | 15-Mar-21 | Market Sale | 6,708 | $124.56 | $835,548.00 | (< 1%) 8.61M to 8.61M | 20% |
16-Mar-21 4:17 PM View: | Allakos Inc. (ALLK) | 12-Mar-21 | Market Sale | 4,071 | $124.18 | $505,537.00 | (< 1%) 8.62M to 8.61M | 20% |
11-Mar-21 7:35 PM View: | Allakos Inc. (ALLK) | 11-Mar-21 | Market Sale | 6,006 | $124.62 | $748,468.00 | (< 1%) 8.62M to 8.62M | 20% |
11-Mar-21 7:35 PM View: | Allakos Inc. (ALLK) | 09-Mar-21 | Market Sale | 100 | $125.00 | $12,500.00 | (< 1%) 8.62M to 8.62M | 21% |
29-May-20 4:40 PM View: | Esperion Therapeutics, Inc. (ESPR) | 28-May-20 | Grant | 6,106 | -- | -- | 21% 29.53K to 35.64K | |
03-Sep-19 5:23 PM View: | Krystal Biotech, Inc. (KRYS) | 30-Aug-19 | Market Sale | 32,190 | $46.18 | $1,486,530.00 | (8%) 398.55K to 366.36K | |
03-Sep-19 5:23 PM View: | Krystal Biotech, Inc. (KRYS) | 29-Aug-19 | Market Sale | 56,494 | $46.62 | $2,633,810.00 | (12%) 455.05K to 398.55K | |
31-May-19 4:51 PM View: | Esperion Therapeutics, Inc. (ESPR) | 29-May-19 | Grant | 4,967 | -- | -- | 20% 24.57K to 29.53K | |
02-Jan-19 3:48 PM View: | PLC Systems Inc. (VIVE) | 31-Dec-18 | Grant | 21,131 | -- | -- | 1% 1.42M to 1.44M | |
04-Oct-18 1:17 PM View: | PLC Systems Inc. (VIVE) | 01-Oct-18 | Grant | 8,947 | -- | -- | < 1% 1.41M to 1.42M | |
01-Oct-18 5:18 PM View: | Sutro Biopharma, Inc. (STRO) | 01-Oct-18 | Conversion Duplicate | 1,944,900 | -- | -- | 100% 0 to 1.94M | |
23-Jul-18 5:03 PM View: | Allakos Inc. (ALLK) | 23-Jul-18 | Conversion Duplicate | 11,269,200 | -- | -- | 100% 11.27M to 22.54M | |
23-Jul-18 5:03 PM View: | Allakos Inc. (ALLK) | 23-Jul-18 | Purchase Duplicate | 250,000 | $18.00 | $4,500,000.00 | 1% 22.54M to 22.79M | |
03-Jul-18 6:23 PM View: | PLC Systems Inc. (VIVE) | 02-Jul-18 | Grant | 8,437 | -- | -- | < 1% 1.4M to 1.41M | |
04-Apr-18 5:43 PM View: | PLC Systems Inc. (VIVE) | 02-Apr-18 | Grant | 6,450 | -- | -- | < 1% 1.4M to 1.4M | |
31-May-19 4:51 PM View: | Esperion Therapeutics, Inc. (ESPR) | 28-Feb-18 | Acquisition (other) | 24,565 | -- | -- | 100% 0 to 24.57K | |
29-May-20 4:40 PM View: | Esperion Therapeutics, Inc. (ESPR) | 28-Feb-18 | Acquisition (other) Duplicate | 24,565 | -- | -- | 495% 4.97K to 29.53K | |
22-Jan-18 8:49 PM View: | Esperion Therapeutics, Inc. (ESPR) | 18-Jan-18 | Payment of Exercise | 6,640 | $74.96 | $497,734.00 | (1%) 631.2K to 624.56K | 62% |
22-Jan-18 8:49 PM View: | Esperion Therapeutics, Inc. (ESPR) | 18-Jan-18 | Option Exercise | 71,237 | $6.99 | $497,947.00 | 13% 559.97K to 631.2K | |
04-Jan-18 9:53 PM View: | PLC Systems Inc. (VIVE) | 02-Jan-18 | Grant | 4,276 | -- | -- | < 1% 1.39M to 1.4M | |
22-Jan-18 8:49 PM View: | Esperion Therapeutics, Inc. (ESPR) | 29-Dec-17 | Gift | 38,486 | -- | -- | (6%) 598.45K to 559.97K | |
04-Oct-17 8:34 PM View: | PLC Systems Inc. (VIVE) | 02-Oct-17 | Grant | 2,872 | -- | -- | < 1% 1.39M to 1.39M | |
25-Sep-17 5:28 PM View: | Krystal Biotech, Inc. (KRYS) | 22-Sep-17 | Conversion | 124,456 | -- | -- | 95% 130.59K to 255.05K | |
25-Sep-17 5:28 PM View: | Krystal Biotech, Inc. (KRYS) | 22-Sep-17 | Purchase | 200,000 | $10.00 | $2,000,000.00 | 78% 255.05K to 455.05K | |
08-Sep-17 8:36 PM View: | PLC Systems Inc. (VIVE) | 06-Sep-17 | Grant | 3,025 | -- | -- | < 1% 1.39M to 1.39M | |
19-May-17 8:20 PM View: | PLC Systems Inc. (VIVE) | 17-May-17 | Grant | 2,387 | -- | -- | < 1% 1.39M to 1.39M | |
19-May-17 8:20 PM View: | PLC Systems Inc. (VIVE) | 17-May-17 | Grant Duplicate | 2,387 | -- | -- | < 1% 1.39M to 1.39M | |
23-Mar-17 4:45 PM View: | Esperion Therapeutics, Inc. (ESPR) | 21-Mar-17 | Market Sale | 350,000 | $45.80 | $16,029,300.00 | (20%) 1.72M to 1.37M | 39% |
21-Mar-17 6:48 PM View: | PLC Systems Inc. (VIVE) | 17-Mar-17 | Market Purchase | 500,000 | $4.00 | $2,000,000.00 | 56% 885.01K to 1.39M | (99%) |
14-Nov-16 4:03 PM View: | PLC Systems Inc. (VIVE) | 09-Nov-16 | Grant | 1,775 | -- | -- | < 1% 883.23K to 885.01K | |
24-Aug-16 8:56 PM View: | PLC Systems Inc. (VIVE) | 22-Aug-16 | Grant | 1,279 | -- | -- | < 1% 881.96K to 883.23K | |
20-Jun-16 5:08 PM View: | PLC Systems Inc. (VIVE) | 17-Jun-16 | Market Purchase | 200,000 | $5.00 | $1,000,000.00 | 29% 681.95K to 881.95K | (99%) |
25-Nov-15 3:21 PM View: | PLC Systems Inc. (VIVE) | 24-Nov-15 | Private Purchase Duplicate | 857,142 | $0.70 | $599,999.00 | 19% 4.6M to 5.46M | |
14-May-15 5:45 PM View: | PLC Systems Inc. (VIVE) | 12-May-15 | Market Purchase | 2,702,700 | $0.37 | $1,000,000.00 | 143% 1.9M to 4.6M | (99%) |
25-Nov-14 7:09 PM View: | Evofem Biosciences, Inc. (EVFM) | 25-Nov-14 | Conversion | 2,497,650 | -- | -- | 63489% 3.93K to 2.5M | |
25-Nov-14 7:09 PM View: | Evofem Biosciences, Inc. (EVFM) | 25-Nov-14 | Purchase Duplicate | 70,000 | $14.00 | $980,000.00 | 3% 2.5M to 2.57M | |
25-Nov-14 7:09 PM View: | Evofem Biosciences, Inc. (EVFM) | 25-Nov-14 | Sale | 149,286 | $14.00 | $2,090,000.00 | (5%) 2.82M to 2.67M | |
25-Nov-14 7:09 PM View: | Evofem Biosciences, Inc. (EVFM) | 25-Nov-14 | Exercise (in-the money or at-the-money) | 244,729 | $9.59 | $2,347,590.00 | 10% 2.57M to 2.82M | |
21-Oct-14 6:53 PM View: | Esperion Therapeutics, Inc. (ESPR) | 21-Oct-14 | Private Purchase Duplicate | 500,000 | $20.00 | $10,000,000.00 | 24% 2.05M to 2.55M |